Parallel Advisors, LLC Bluebird Bio, Inc. Transaction History

Parallel Advisors, LLC

$4.18 Billion
Q3 2024

26 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 May 20, 2024	SELL	$3.02 - $4.05 $84 - $113	-28 Reduced 75.68%	9 $0
Q3 2023 Nov 13, 2023	SELL	$3.02 - $4.05 $84 - $113	-28 Reduced 75.68%	9 $0
Q2 2023 May 20, 2024	BUY	$2.79 - $5.03 $78 - $140	28 Added 311.11%	37 $0
Q2 2023 Aug 04, 2023	BUY	$2.79 - $5.03 $78 - $140	28 Added 311.11%	37 $0
Q1 2023 May 20, 2024	BUY	$3.14 - $8.22 $28 - $73	9 New	9 $0
Q1 2023 Apr 25, 2023	SELL	$3.14 - $8.22 $172 - $452	-55 Reduced 85.94%	9 $0
Q3 2022 Nov 10, 2022	BUY	$3.75 - $7.39 $206 - $406	55 Added 611.11%	64 $0
Q2 2022 Aug 01, 2022	SELL	$2.94 - $5.23 $97 - $172	-33 Reduced 78.57%	9 $0
Q1 2022 Apr 28, 2022	SELL	$4.07 - $10.6 $447 - $1,166	-110 Reduced 72.37%	42 $0
Q3 2021 Nov 02, 2021	BUY	$11.24 - $21.0 $944 - $1,764	84 Added 123.53%	152 $3,000
Q2 2021 Aug 06, 2021	BUY	$18.04 - $22.09 $198 - $242	11 Added 19.3%	68 $2,000
Q1 2021 Apr 23, 2021	SELL	$16.59 - $33.89 $2,538 - $5,185	-153 Reduced 72.86%	57 $2,000
Q4 2020 Feb 02, 2021	SELL	$27.5 - $37.92 $1,292 - $1,782	-47 Reduced 18.29%	210 $9,000
Q3 2020 Oct 27, 2020	BUY	$34.44 - $43.75 $2,307 - $2,931	67 Added 35.26%	257 $14,000
Q2 2020 Jul 16, 2020	BUY	$27.12 - $45.97 $2,928 - $4,964	108 Added 131.71%	190 $11,000
Q1 2020 Apr 27, 2020	SELL	$26.16 - $63.5 $235 - $571	-9 Reduced 9.89%	82 $3,000
Q4 2019 Jan 30, 2020	BUY	$46.96 - $61.67 $4,132 - $5,426	88 Added 2933.33%	91 $8,000
Q2 2019 Aug 05, 2019	SELL	$75.84 - $105.21 $1,289 - $1,788	-17 Reduced 85.0%	3 $0
Q1 2019 May 01, 2019	BUY	$64.44 - $104.11 $708 - $1,145	11 Added 122.22%	20 $3,000
Q4 2018 Feb 05, 2019	SELL	$59.1 - $93.26 $591 - $932	-10 Reduced 52.63%	9 $0
Q3 2018 Nov 01, 2018	SELL	$88.86 - $117.49 $710 - $939	-8 Reduced 29.63%	19 $3,000
Q2 2018 Jul 30, 2018	BUY	$99.64 - $127.59 $597 - $765	6 Added 28.57%	27 $4,000
Q1 2018 May 08, 2018	BUY	$105.8 - $150.94 $846 - $1,207	8 Added 61.54%	21 $4,000
Q3 2017 Nov 15, 2017	BUY	$57.74 - $91.42 $750 - $1,188	13 New	13 $2,000
Q3 2017 Nov 14, 2017	SELL	$57.74 - $91.42 $461 - $731	-8 Closed	0 $0
Q2 2017 Aug 07, 2017	BUY	N/A	8	8 $1,000

Others Institutions Holding BLUE

# of Institutions

112

Shares Held

61.5M

Call Options Held

264K

Put Options Held

428K

Black Rock Inc. New York, NY

15.4M
Shares

$97.1 Million
0.0% of portfolio
Vanguard Group Inc Valley Forge, PA

10.5M
Shares

$65.9 Million
0.0% of portfolio
Geode Capital Management, LLC Boston, MA

4.68M
Shares

$29.5 Million
0.0% of portfolio
Pictet Asset Management Sa Geneva 73, V8

4.67M
Shares

$29.4 Million
0.02% of portfolio
State Street Corp Boston, MA

3.84M
Shares

$24.2 Million
0.0% of portfolio

View Full List

About bluebird bio, Inc.

Ticker BLUE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 77,121,800
Market Cap $485M
Description
bluebird bio, Inc., a biotechnology company, researches, develops, and commercializes transformative gene therapies for severe genetic diseases. Its product candidates for severe genetic diseases include betibeglogene autotemcel for the treatment of transfusion-dependent ß-thalassemia; lovotibeglogene autotemcel for the treatment of sickle cell ...

More about BLUE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Parallel Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Parallel Advisors, LLC with notifications on news.

Account